Company Info
Year Established2018
Contacts
S. Alex JacobsonInterim CEO
Nina Horowitz, PhD
CSO
Company Description
ImmuneBridge is developing allogeneic immunotherapies for cancer.
2018
Interim CEO
Nina Horowitz, PhD
CSO
2018
Interim CEO
Nina Horowitz, PhD
CSO